New model could benefit liver cancer transplant patients
A simple blood test may better predict which patients diagnosed with liver cancer will experience disease recurrence, according to new research from Weill Cornell Medicine scientists. The findings may help physicians determine who would benefit most from a liver transplant.
Depending on disease severity, oncologists may recommend liver transplantation for patients whose tumors have not yet metastasized. Physicians have traditionally used a special set of criteria, based on the size and number of tumors, to assess patients' risk of cancer reoccurrence if they receive a new organ – the findings from which ultimately determine if transplantation is the appropriate treatment....

http://medicalxpress.com/news/2016-12-benefit-liver-cancer-transplant-patients.html
Like
Comment
Share